Roche Aktie
282,15
EUR
+4,00
EUR
+1,44
%
265,50
CHF
+5,30
CHF
+2,04
%
Werbung
Roche Aktie Analyse
01.02.19 | Roche Reduce | HSBC | |
18.10.18 | Roche Underperform | Credit Suisse Group | |
11.09.18 | Roche Underperform | BNP PARIBAS | |
27.07.18 | Roche Reduce | HSBC | |
27.07.18 | Roche Underperform | Credit Suisse Group | |
15.06.18 | Roche Underperform | Credit Suisse Group | |
06.06.18 | Roche Reduce | HSBC | |
04.06.18 | Roche Underweight | Morgan Stanley | |
Werbung
|
|||
31.05.18 | Roche Reduce | HSBC | |
25.05.18 | Roche Underperform | Credit Suisse Group | |
17.04.18 | Roche Underweight | Morgan Stanley | |
27.03.18 | Roche Underweight | Morgan Stanley | |
14.03.18 | Roche Sell | Société Générale Group S.A. (SG) | |
15.01.18 | Roche Sell | Société Générale Group S.A. (SG) | |
21.11.17 | Roche Reduce | HSBC | |
20.10.17 | Roche Reduce | HSBC | |
25.09.17 | Roche Underperform | BNP PARIBAS | |
15.09.17 | Roche Reduce | HSBC | |
12.09.17 | Roche Reduce | HSBC | |
11.07.17 | Roche Reduce | HSBC | |
06.06.17 | Roche Reduce | HSBC | |
07.04.17 | Roche Reduce | HSBC | |
28.09.15 | Roche verkaufen | Goldman Sachs Group Inc. |
Werbung
Werbung